Delivery Order SPE2DB22D2214-SPE2DB23FS5UU

Award Date 8/7/23
Potential Completion Date 8/8/23
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $107 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Olopatadine hydrochloride 0.1% eye drops. As the prime contractor, Amerisourcebergen will supply five milliliters of the ophthalmic solution to a facility in Conshohocken, Pennsylvania under a one-day period of performance concluding on July 13, 2023. The order was placed against an existing DLA contract vehicle and no subcontractors or set aside designations were indicated. This...
The Defense Logistics Agency awarded a $228,750 firm fixed-price delivery order to Amerisourcebergen Drug Corporation for olopatadine hydrochloride 0.1% eye drops. Under this contract, Amerisourcebergen will deliver 5 milliliter bottles of the eye drops to a location in Conshohocken, Pennsylvania between September 1-5, 2023. The Defense Logistics Agency manages the Department of Defense's global supply chain and is responsible for procuring various pharmaceutical and medical supplies to...
The Defense Logistics Agency awarded a $531 delivery order to Amerisourcebergen Drug Corporation for olopatadine hydrochloride 0.1% eye drops. As the prime contractor, Amerisourcebergen will supply 5mL bottles of the eye drops to the DLA under a firm fixed price contract set to be completed by July 10, 2023. The place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania. No subcontractors or set aside designations were indicated. This delivery order is likely in...
The Defense Logistics Agency awarded a $320,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Olopatadine hydrochloride 0.1% eye drops. Under this contract, Amerisourcebergen will provide 5 milliliter bottles of the eye drops to support DLA programs. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day, from June 20th through June 21st, 2023. No subcontractors or set aside designations were identified. This...
The Defense Logistics Agency awarded a $107,280 delivery order to Amerisourcebergen Drug Corporation for Olopatadine hydrochloride 0.1% eye drops. The firm fixed price order is for 5 milliliter bottles of the eye drops and will be fulfilled by Amerisourcebergen from its facility in Conshohocken, Pennsylvania between July 13-14, 2023. No major subcontractors or set aside designations were identified. The Defense Logistics Agency manages the global supply chain for the United States military and...
The Defense Logistics Agency awarded a $436.52 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Olopatadine hydrochloride 0.1% eye drops. The prime contractor will deliver 5mL bottles of the eye drops to a location in Conshohocken, Pennsylvania by June 30, 2023 in support of Department of Defense requirements. Amerisourcebergen will perform under this single award delivery order placed against an existing DLA pharmaceuticals contract vehicle. No subcontractors or set...
The Defense Logistics Agency awarded a $398 firm fixed price delivery order to Amerisourcebergen Drug Corporation for olopatadine hydrochloride 0.1% eye drops. As the prime contractor, Amerisourcebergen will supply 5mL bottles of the eye drops to the DLA for use in agency programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a two-day period in September 2023. No subcontractors or set aside designations were indicated. The DLA manages the global...
The Defense Logistics Agency awarded a $322,260 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Olopatadine hydrochloride 0.1% eye drops. The prime contractor will deliver 5 milliliter bottles of the eye drops to a location in Conshohocken, Pennsylvania by July 13, 2023 in support of Department of Defense requirements. Amerisourcebergen will perform under this single award delivery order against an existing DLA pharmaceuticals contract vehicle. No subcontractors or...
The Defense Logistics Agency awarded a $217 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation for the supply of 5ml bottles of 0.1% olopatadine hydrochloride eye drops. As the prime contractor, Amerisourcebergen will deliver the eye drops to a location in Conshohocken, Pennsylvania within the period of performance from July 7-10, 2023. No subcontractors or set aside designations were identified. This order is consistent with DLA's mandate to procure pharmaceuticals...
The Defense Logistics Agency awarded a $1,086 firm fixed price delivery order to Amerisourcebergen Drug Corporation for olopatadine hydrochloride 0.1% eye drops. Under this contract, Amerisourcebergen will deliver 5 milliliters of the eye drops to a location in Conshohocken, Pennsylvania by September 25, 2023. No additional details were provided about the original solicitation or whether this delivery order is associated with a larger indefinite delivery/indefinite quantity contract vehicle....
  • SPE2DB22D2214
    Indefinite Delivery Contract
  • SPE2DB22D2214-SPE2DB23FS5UU
    Delivery Order

The Defense Logistics Agency awarded a $1,272 firm fixed price delivery order to Amerisourcebergen Drug Corporation for olopatadine hydrochloride 0.1% eye drops. The single award was issued under an indefinite-delivery/indefinite-quantity contract vehicle to supply 5mL bottles of the ophthalmic solution. Performance will occur at the prime contractor's facility in Conshohocken, Pennsylvania over a one day period in August 2023. No subcontractors or set aside designations were identified. The order supports the DLA's medical supply chain responsibilities for the U.S. Department of Defense.

Generated 12/14/23, 6:55 PM